Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,679,509
-$1,283,882 QoQ
Shares Held
68,685
-12.5% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. PTCT ranks #20 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in PTCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,679,509 | 68,685 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,963,391 | 78,507 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,198,431 | 101,001 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,768,200 | 97,629 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,908,134 | 57,067 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,522,364 | 78,032 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,756,857 | 101,263 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,072,066 | 100,460 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,561,303 | 294,304 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,369,380 | 339,963 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,622,891 | 206,287 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,853,987 | 193,115 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,626,538 | 157,443 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,071,046 | 211,450 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,483,731 | 129,158 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,869,373 | 121,552 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,946,840 | 159,390 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,661,953 | 142,153 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,957,860 | 79,491 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,567,352 | 60,737 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,699,139 | 57,004 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $875,597 | 14,347 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,034,232 | 43,513 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $983,899 | 19,391 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $313,608 | 7,030 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||